Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Albumin and Vasoconstrictor Agents

Research Papers that Mention the Interaction

The clinical management of hepatorenal syndrome is currently based on the use of a vasoconstrictor in association with albumin.
Annals of hepatology  •  2019  |  View Paper
The long-term administration (1-3 weeks) of analogs of vasopressin (ornipressin or terlipressin) or other vasoconstrictors together with plasma volume expansion with albumin is associated with a dramatic improvement in circulatory function and normalization of serum creatinine concentration in patients with severe hepatorenal syndrome.
Journal of hepatology  •  2000  |  View Paper
These data suggest that albumin administration reduced the activation of endogenous vasoconstrictor systems and protected patients from further impairment of renal function.
Journal of gastroenterology and hepatology  •  2020  |  View Paper
That is, HRS has an additional structural component that would not only make traditional diagnostic criteria less reliable but would explain the lack of response to pharmacological treatment with vasoconstrictors plus albumin that correlates with a progressive increase in inflammation.
Journal of hepatology  •  2019  |  View Paper
We do agree that albumin can help synergistically the vasoconstrictors.
Hepatology  •  2019  |  View Paper
In addition, improvement of circulatory dysfunction with the use of albumin and vasoconstrictors may prevent hepatic encephalopathy in acute-on-chronic liver failure.
Current opinion in critical care  •  2011  |  View Paper
Vasoconstrictors plus albumin improve renal function in 40–60% of patients with type 1 HRS.
Nature Reviews Nephrology  •  2011  |  View Paper
Moreover, results of treatment with vasoconstrictors in hepatorenal syndrome are significantly improved with the use of albumin.
Annals of hepatology  •  2011  |  View Paper
Vasoconstrictors together with albumin can ameliorate the effective arterial blood volume and increase renal perfusion pressure.
Hepato-gastroenterology  •  2010  |  View Paper
Conclusion:In hypotensive neonates, ALB results in a greater likelihood of achieving normotension and decreased subsequent use of vasopressors when compared to NS.
Journal of Perinatology  •  2008  |  View Paper
Show More